A major breakthrough in cancer study is arising with the use of VHH fragments to re-engage mutated p53. This crucial malignant protector protein is frequently disabled in several types of malignancies, leading https://linkingbookmark.com/story21837862/mini-antibodies-restore-p53-new-potential-pathway-for-tumor-management